NIZO cooperated with partners to valorise olive leaf biomass that is rich in bioactive compounds such as polyphenols. To substantiate health benefits, in vitro fecal fermentation in the MicroColon model was combined with a co-culture model comprising intestinal cells and immune cells. Several olive leaf bioproducts were found to have potential health benefits on gut health and beyond.
Based in Ede, the Netherlands, NIZO is a globally leading, private, and independent contract research organization specializing in food and health innovation for over 75 years. Operating the largest open access food-grade pilot plant in Europe, we leverage the integrated power of science and technology to help our customers in transforming food and nutrition more successfully, sustainably and efficiently; ultimately leading to better food and health.
As a NIZO customer, you will benefit from exclusive access to the NIZO Pilot Plant – the largest open-access, food-grade pilot plant in Europe – equipped with €5 million in recent state-of-the-art upgrades.
